Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation

Small hepatocellular carcinoma is an important leading cause of death amongst cancer patients, our study was designed in order to test the hypothesis that radiofrequency ablation (RFA) combined with a chemotherapeutic drug would improve the outcome for patients. Two groups of patients presenting ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Quanyou, Qin, Zhaoxia, Hou, Fangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754899/
https://www.ncbi.nlm.nih.gov/pubmed/29344133
http://dx.doi.org/10.3892/ol.2017.7174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754899/
https://www.ncbi.nlm.nih.gov/pubmed/29344133
http://dx.doi.org/10.3892/ol.2017.7174

Ejemplares similares